— Know what they know.
Not Investment Advice
Also trades as: 0JZ2.L (LSE) · $vol 0M

MASI NASDAQ

Masimo Corporation
1W: +0.6% 1M: +0.9% 3M: +2.5% YTD: +41.2% 1Y: +7.8% 3Y: +9.6% 5Y: -13.9%
$179.95
Last traded 2026-06-12 — delisted
NASDAQ · Healthcare · Medical - Devices · $9.4B mcap · 44M float · 2.43% daily turnover · Short 49% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$1.5B -27.1% ▼
5Y CAGR: +5.9%
Gross Profit
$945M -5.9% ▼
5Y CAGR: +4.9%
Operating Income
$313M +217.3% ▲
5Y CAGR: +4.1%
Net Income
-$152M +50.3% ▲
EPS (Diluted)
$-2.80 +51.0% ▲
EBITDA
$345M +317.1% ▲
5Y CAGR: +3.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.2B$2.0B$2.0B$2.1B$1.5B
YoY Growth+8.4%+64.3%+0.6%+2.3%-27.1%
Cost of Revenue$431M$977M$1.0B$1.1B$582M
Gross Profit$808M$1.1B$1.0B$1.0B$945M
Gross Margin65.2%52.0%49.0%48.0%61.9%
R&D Expenses$137M$191M$175M$223M$126M
SG&A Expenses$395M$657M$664M$744M$506M
Operating Expenses$533M$849M$867M$1.3B$632M
Operating Income$276M$210M$136M-$267M$313M
Operating Margin22.3%10.3%6.7%-12.7%20.5%
Interest Expense$300K$26M$50M$44M$33M
Income Before Tax$274M$193M$88M-$305M$273M
Tax Expense$45M$50M$7M-$400K$65M
Net Income$230M$144M$82M-$305M-$152M
Net Margin18.5%7.0%4.0%-14.6%-9.9%
EPS (Diluted)$3.98$2.60$1.51$-5.72$-2.80
EBITDA$310M$355M$237M-$159M$345M
Shares Outstanding58M55M54M53M54M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms